U.S. Stock News

If you are wondering whether Corcept Therapeutics at around US$51.42 is attractively priced or already stretched, starting with a clear view of valuation can help frame your next move. The stock has seen sharp swings recently, with returns of 11.6% over 7 days, 22.5% over 30 days, 34.6% year to date, but a 29.3% decline over the past year and gains of 113.6% over 3 years and 143.7% over 5 years. Recent coverage has focused on how this price history shapes expectations for Corcept...

For investors considering whether Travelers Companies at around US$304.72 represents fair value or whether the price may be ahead of itself, this article examines what the available numbers indicate about the stock. The share price has moved by 0.7% over the past week, 4.9% over the last month, 6.8% year to date and 15.8% over the past year. These figures provide useful context before assessing the underlying value. Recent news coverage has focused on Travelers Companies as a major U.S...

What Airbnb’s recent performance signals for investors Without a specific news headline driving attention, Airbnb (ABNB) is on investors’ radar as its share price, recent returns, and profitability metrics offer fresh context for assessing the short term trade off between growth and value. See our latest analysis for Airbnb. With the share price at US$141.66 after a positive 1 day share price return of 0.93%, recent momentum has been shaped more by the 13.16% 30 day share price return and a...

Why CarGurus Stock Is on Investors’ Radar CarGurus (CARG) has drawn investor interest after recent trading left the shares around US$37.04, with returns over the past month and past 3 months outpacing its year to date performance. See our latest analysis for CarGurus. That recent move to US$37.04 follows a 10.4% 30 day share price return and a 14.3% 90 day share price return, set against a year to date share price return that is slightly negative and a 31.4% 1 year total shareholder return...

NIO (NIO) is back in focus after April deliveries reached 29,356 vehicles and the All New ES8 crossed 100,000 cumulative units, alongside expanded 900V technology collaboration with Onsemi and the Onvo L80 rollout. See our latest analysis for NIO. Despite the recent 1 day share price return of a 7.51% decline to $5.91 and a 7 day share price return of a 4.83% decline, NIO has a 90 day share price return of 25.74% and a 1 year total shareholder return of 46.65%, although the 5 year total...

Omega Healthcare Investors (OHI) opened 2026 with Q1 revenue of US$323 million and basic EPS of US$0.47, alongside funds from operations of US$249 million and FFO per share of US$0.84, setting a clear snapshot of cash generation and earnings at the start of the year. Over the past reported quarters, revenue has moved from US$277 million in Q1 2025 to US$319 million in Q4 2025 and EPS has ranged between US$0.34 and US$0.60 over that period. This gives investors a recent history of how the top...

Wondering if American Healthcare REIT is reasonably priced at around US$50 a share, or if the market is getting ahead of itself? This article walks through what the current numbers actually say about value. The stock recently closed at US$50.15, with returns of 0.1% over 7 days, 5.5% over 30 days, 6.2% year to date and 57.7% over the past year. This naturally raises questions about how much of the story is already reflected in the price. Recent coverage has focused on American Healthcare...

Align Technology (ALGN) opened 2026 with Q1 revenue of about US$1.0 billion and basic EPS of US$1.58, setting the tone for how investors will read the rest of the year. The company has seen quarterly revenue move from US$979.3 million in Q1 2025 through US$995.2 million in Q4 2024 to just over US$1.0 billion in the latest quarter, while basic EPS over the same span ranged from US$1.27 in Q1 2025 to US$1.89 in Q4 2025 before landing at US$1.58 in Q1 2026. This provides a clear run-rate on both...

Why Kyivstar’s Ukraine investment program matters for VEON (NasdaqGS:VEON) VEON (NasdaqGS:VEON) is back in focus after Kyivstar completed a multi year, US$1.3b investment program in Ukraine ahead of schedule, surpassing the group’s original 2023 to 2027 commitment by 30%. See our latest analysis for VEON. VEON’s latest Ukraine update comes as the share price trades at US$49.74, with a 7.43% 1 month share price return but a 5.62% decline year to date. The 3 year total shareholder return of...

O'Reilly Automotive (ORLY) opened 2026 with Q1 revenue of US$4.6b and basic EPS of US$0.72, supported by trailing twelve month revenue of US$18.2b and EPS of US$3.08 that point to earnings growth of 9.5% over the past year. Over the last five reported quarters, the company has seen revenue move from US$4.1b in Q1 2025 to US$4.6b in Q1 2026, while quarterly EPS ranged between US$0.63 and US$0.86 across that period as trailing net income reached US$2.6b. With net profit margins running at...

This article examines whether StoneCo, trading at around US$10.98, could be considered a bargain or a value trap by focusing on what the current share price might imply about the company. The stock has experienced significant recent volatility, with a 24.5% decline over the last week, a 22.2% decline over the last month, and a 25.3% decline year to date. Over longer periods, the 1 year return shows a 4.3% decline and the 5 year return a 78.3% decline. Recent commentary around StoneCo has...

Why PulteGroup is on investors’ radar today PulteGroup (PHM) is back on many watchlists after recent share price moves, including a 1.4% gain over the last day, a 6.3% decline over the past week, and mixed returns over the month and past 3 months. See our latest analysis for PulteGroup. That short-term pullback, with a 7 day share price return of a 6.3% decline, sits against a much stronger backdrop that includes a 1 year total shareholder return of 21.1% and a 5 year total shareholder return...

If you are wondering whether Tradeweb Markets at around US$113 per share is a bargain or just fairly priced, you are in the right place to unpack what that current tag might really mean for you. The stock is up 6.6% year to date, has seen a 3.7% decline over the last 30 days and a 0.3% slip over the past week, while the 1 year return sits at a 17.6% loss against a much stronger 63.9% gain over 3 years and 40.6% over 5 years. Recent attention around Tradeweb has focused on its role in...

Structure Therapeutics (NasdaqGM:GPCR) plans multiple presentations at the 86th American Diabetes Association Scientific Sessions. The company will share new safety, efficacy, and dosing data for its oral GLP-1 receptor agonist aleniglipron. Additional data will cover a novel amylin receptor agonist combination, including findings on weight loss effects. The presentations focus on combination approaches in obesity and diabetes treatment development. Structure Therapeutics focuses on oral...

If you are wondering whether Camtek's current share price reflects its underlying value, you are not alone. That question is exactly what this article will help you think through. Camtek's stock has been volatile recently, with a 2% decline over the last week, a 26.6% gain over the last 30 days, a 66.2% return year to date, and a 191.3% return over the last year, along with very large multi year gains. These moves have put Camtek firmly on many investors' radars, and recent coverage has...

Wondering if Truist Financial at around US$51.50 is offering good value right now, or if the easy gains are already behind it. The stock recently closed at US$51.50, with returns of 0.2% over 7 days, 12.0% over 30 days, 3.5% year to date, 39.9% over 1 year and 6.8% over 5 years, which provides a range of recent pricing data to consider. Recent coverage around Truist Financial has focused on its position in the U.S. banking sector and how investors are reassessing established banks. This...

Why Southwest Gas Holdings (SWX) is on investors’ radar Southwest Gas Holdings (SWX) has drawn attention after a sustained stretch of positive returns, including gains over the past week, month, past 3 months and year. This performance is prompting investors to reassess the utility’s current share price. See our latest analysis for Southwest Gas Holdings. The recent 1 month share price return of 8.23% and year to date share price return of 17.34% suggest building momentum, while the 1 year...

In recent years, AutoZone's heavy reliance on debt-funded share buybacks has left the company with liabilities that appear to exceed its assets, raising concerns about the durability of a business model that has produced very large long-term returns for shareholders in the past. These worries are being amplified by higher interest rates and the gradual shift toward electric vehicles, which together may challenge AutoZone's historically dependable cash generation and financial flexibility...

Clorox, NYSE:CLX, has completed its acquisition of GOJO Industries, the owner of the Purell brand. The deal adds a broad health and hygiene portfolio to Clorox's existing cleaning and household products. This transaction reflects a move to broaden Clorox's exposure beyond traditional household categories. Clorox enters this deal with its shares at $96.44, after a 27.3% decline over the past year and a 38.1% decline over the past five years. The acquisition of GOJO and Purell gives the...

Why Old Dominion Freight Line is on investors’ radar now Old Dominion Freight Line (ODFL) has attracted fresh attention after a strong run in its shares over the past year, with returns outpacing shorter term moves over the month and past 3 months. With the stock recently closing at $212.43 and 1 year total return at 42.08%, investors are weighing how the company’s current valuation lines up against its recent revenue and net income figures. See our latest analysis for Old Dominion Freight...

L3Harris Technologies (LHX) has kicked off its Q1 2026 reporting cycle with investors looking back at a steady run of quarterly numbers, where 2025 revenue ranged from US$5,132 million to US$5,659 million and basic EPS moved between US$1.60 and US$2.47. Over the last year, the company has seen total revenue hold around US$21.2 billion on a trailing basis, while trailing EPS has tracked between US$7.91 and US$9.35. This provides a clear sense of consistent top line scale and earnings power as...

If you are wondering whether Warner Bros. Discovery at around US$27.05 is still offering value after a strong run, this breakdown will help you understand what the current price actually reflects. The stock has returned 0.6% over the last week and 220.9% over the past year, even though the year to date return sits at a 5.1% decline and the five year return is a 25.4% decline. Recent headlines have focused on Warner Bros. Discovery's positioning across streaming, film, and TV content, as...

In April 2026, Hamilton Lane launched the Hamilton Lane Credit Income Fund and converted its Private Infrastructure Fund into interval fund structures, offering U.S. investors lower minimums, quarterly liquidity, daily NAVs and 1099 tax reporting, while also introducing a tokenized version of the infrastructure fund via Republic’s digital platform. The new interval funds, already drawing more than US$350 million in commitments, highlight Hamilton Lane’s push to broaden private market access...

Lemonade (LMND) opened Q1 2026 earnings season with Q4 2025 revenue of US$228.4 million and a basic EPS loss of US$0.29, alongside net income excluding extra items of a US$21.7 million loss. Over the past year, the company reported quarterly revenue increasing from US$151.2 million in Q1 2025 to US$228.4 million in Q4 2025, while quarterly basic EPS losses narrowed from US$0.86 in Q1 2025 to US$0.29 in Q4 2025. For investors, the latest results focus attention on how quickly Lemonade can...